Correlation between SARS‐COV‐2 antibody screening by immunoassay and neutralizing antibody testing (2021)
- Authors:
- Mendrone Junior, Alfredo
- Dinardo, Carla Luana
- Ferreira, Suzete Cleuza
- Nishya, Anna
- Salles, Nanci Alves
- Almeida Neto, Cesar de
- Hamasaki, Debora Toshei
- Facincani, Tila
- Alves, Lucas Bassolli de Oliveira
- Machado, Rafael Rahal Guaragna
- Araujo, Danielle Bastos
- Durigon, Edison Luiz
- Rocha, Vanderson Geraldo
- Sabino, Ester Cerdeira
- Mendrone Junior, Alfredo
- USP affiliated authors: DURIGON, EDISON LUIZ - ICB ; ROCHA, VANDERSON GERALDO - FM ; SABINO, ESTER CERDEIRA - FM ; MACHADO, RAFAEL RAHAL GUARAGNA - ICB
- Unidades: ICB; FM
- DOI: 10.1111/trf.16268
- Subjects: MICROBIOLOGIA; COVID-19; IMUNOENSAIO; IMUNOGLOBULINAS; ANTICORPOS; TESTES IMUNOLÓGICOS; PLASMA
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Transfusion
- ISSN: 1537-2995
- Volume/Número/Paginação/Ano: 10 p., 2021
- Este artigo possui versão em acesso aberto
- URL de acesso aberto
- PDF de acesso aberto
- Versão do Documento: Versão publicada (Published version)
-
Status: Artigo possui acesso gratuito no site do editor (Bronze Open Access) -
ABNT
MENDRONE JUNIOR, Alfredo et al. Correlation between SARS‐COV‐2 antibody screening by immunoassay and neutralizing antibody testing. Transfusion, p. 10 , 2021Tradução . . Disponível em: https://doi.org/10.1111/trf.16268. Acesso em: 14 mar. 2026. -
APA
Mendrone Junior, A., Dinardo, C. L., Ferreira, S. C., Nishya, A., Salles, N. A., Almeida Neto, C. de, et al. (2021). Correlation between SARS‐COV‐2 antibody screening by immunoassay and neutralizing antibody testing. Transfusion, 10 . doi:10.1111/trf.16268 -
NLM
Mendrone Junior A, Dinardo CL, Ferreira SC, Nishya A, Salles NA, Almeida Neto C de, Hamasaki DT, Facincani T, Alves LB de O, Machado RRG, Araujo DB, Durigon EL, Rocha VG, Sabino EC. Correlation between SARS‐COV‐2 antibody screening by immunoassay and neutralizing antibody testing [Internet]. Transfusion. 2021 ;10 .[citado 2026 mar. 14 ] Available from: https://doi.org/10.1111/trf.16268 -
Vancouver
Mendrone Junior A, Dinardo CL, Ferreira SC, Nishya A, Salles NA, Almeida Neto C de, Hamasaki DT, Facincani T, Alves LB de O, Machado RRG, Araujo DB, Durigon EL, Rocha VG, Sabino EC. Correlation between SARS‐COV‐2 antibody screening by immunoassay and neutralizing antibody testing [Internet]. Transfusion. 2021 ;10 .[citado 2026 mar. 14 ] Available from: https://doi.org/10.1111/trf.16268 - Cross-lineage protection between chikv primary infection and mayv secondary exposure in mice
- Convalescent plasma for COVID-19 in hospitalised patients: an open-label, randomised clinical trial
- Identification and Characterization of Hematopoietic Stem Cell Transplant Candidates in a Sickle Cell Disease Cohort
- Is Severity Score Associated With Indication for Hematopoietic Stem Cell Transplantation in Individuals With Sickle Cell Anemia?
- A longitudinal study of convalescent plasma (CCP) donors and correlation of ABO group, initial neutralizing antibodies (nAb), and body mass index (BMI) with nAb and anti‐nucleocapsid (NP) SARS‐CoV‐2 antibody kinetics: proposals for better quality of CCP collections
- Anti‐A and SARS‐CoV‐2: an intriguing association
- Nebulized enriched heparin improves respiratory parameters in patients with COVID-19: a phase I/II randomized and triple-blind clinical trial
- Nebulized enriched heparin to treat no critical patients with Sars-Cov-2: triple-blind clinical trial
- Surrogate test performance for SARS-CoV-2 neutralizing antibodies (nAbs) for convalescent plasma (CCP): how useful could they be?
- Prevalence and laboratorial determinants of the clinical relevance of antibodies of undetermined specificity
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
